Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Nova Mentis Life Science Corp. C.LIB

Nova Mentis Life Science Corp is a Canadian-based company focused on building and supporting a diversified portfolio of health and wellness businesses. Through its subsidiary, the company is focused on exploring the anti-inflammatory effects of psilocybin in underexplored metabolic indications such as obesity and diabetes and providing a Health Canada Standard Licensed facility focused on the cultivation of AAAA premium, small batch, terpene rich dominant cultivars cured to perfection.


CSE:LIB - Post by User

Comment by jvosh123on Apr 25, 2018 2:35pm
52 Views
Post# 27939599

RE:RE:RE:Patience

RE:RE:RE:Patience I cant speak for everyone, but certainly a majority of us have done realy, really well on weed stocks.

I would just hope that most of us were smart enough to sell off some of their holdings during the late Dec and Feb run up.  I know I sold a good chunk of LIb then, and have been slowly been adding when I could under .4

It is hard to say that any stock can get anywhere. It is all about market sentiment.  

What lib has going for it is the managment, two applications, and a tight float.

I dont think we are gonna see the crazy run up, even with the pending licenses..but assuming that both are granted, and anything comes of the CBD trials, this could be a 1.50 at a low end...but as well all know, market sets the value.

GL
<< Previous
Bullboard Posts
Next >>